-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares

PUBT·07/24/2026 20:31:37
Listen to the news
United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on July 23, 2026.
  • A family trust sold 11,500 shares the same day at weighted-average prices ranging from USD 522.87 to USD 531.83.
  • The trust’s common-stock stake fell to 324,443 shares following the sales.
  • The filing also showed 40,513 shares held directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000105), on July 24, 2026, and is solely responsible for the information contained therein.